期刊文献+

持续肾替代治疗改善急性心肌梗死合并心肾功能不全患者PCI术后心肾功能和预后的作用 被引量:4

Effect of continuous renal replacement therapy on improving cardiac and renal function and prognosis of patients with acute myocardial infarction complicated with cardiac and renal insufficiency after PCI
下载PDF
导出
摘要 目的探究持续肾替代治疗(CRRT)改善急性心肌梗死合并心肾功能不全患者经皮冠状动脉介入治疗(PCI)术后心肾功能和预后的作用。方法回顾性分析2016年3月-2018年10月在扬中市人民医院及牡丹江医学院附属二院接受PCI治疗的96例急性心肌梗死合并心肾功能不全患者的资料。其中对照组40例PCI术后常规静脉水化治疗,观察组56例PCI治疗前后均行CRRT。观察PCI术前、PCI术后24、48和72 h,两组患者血肌酐(Scr)、尿素氮(BUN)、肾小球滤过率(eGFR)、中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、氨基末端脑钠肽前体(NT-proBNP)、C反应蛋白(CRP)水平;观察两组对比剂肾病(CIN)发生率。结果PCI术后24h,观察组Scr、BUN、NGAL、NT-proBNP、CRP水平较PCI术前下降(P<0.05);对照组Scr水平比术前增加45μmol/L左右;两组eGFR水平较PCI术前上调,观察组上调幅度更显著(P<0.05).PCI术后48、72 h,观察组Scr、BUN、NGAL、NT-proBNP、CRP水平显著下降(P<0.05),eGFR水平显著上升(P<0.05);对照组Scr、BUN、NGAL、NT-proBNP、CRP水平较PCI术后24 h显著下降,eGFR水平显著上升(P<0.05)。观察组APACHEⅡ评分、CIN发生率显著低于对照组,差异均有统计学意义(P<0.05)。结论CRRT能够明显改善急性心肌梗死合并心肾功能不全患者PCI术后的心肾功能,减少CIN的发生,从而有利于患者PCI术后恢复。 Objective To explore the effect of continuous renal replacement therapy on improving cardiac and renal function and prognosis of patients with acute myocardial infarction complicated with cardiac and renal insufficiency after PCI.Methods A retrospective analysis was made on 96 patients with acute myocardial infarction complicated with cardiac and renal insufficiency who received PCI treatment in Yangzhong People's Hospital and the second Affiliated Hospital of Mudanjiang Medical College from March 2016 to October 2018.40 patients were divided into control group according to different treatment methods.Patients were only treated with intravenous hydration after PCI.56 patients in the observation group were treated with CRRT before and after PCI.The levels of serum creatinine(Scr),urea nitrogen(BUN),glomerular filtration rate(eGER),neutrophil gelatinase-associated lipocalin(NGAL),amino-terminal brain natriuretic peptide precursor(NT-proBNP)and C-reactive protein(CRP)were observed before PCI,24 hours after PCI and 48 hours after PCI.The incidence of contrast nephropathy(CIN)in the two groups was observed.Results 24 hours after PCI,the levels of Scr,BUN,NGAL,NT-proBNP and CRP in the observation group were lower than those before PCI(P<0.05).The Scr level of patients in the control group increased by 45p,mol/L compared with that before PCI,and the eG-FR level of patients in the two groups was up-regulated compared with that before PCI,and the up-regulation range in the observation group was more significant(P<0.05).The levels of Scr,BUN,NGAL,NT-proBNP and CRP in the observation group decreased significantly at 48,721i after PCI(P<0.05).The eGFR level of patients in the observation group increased significantly at 48,72 h after PCI(P<0.05).At 48,72 h after PCI,the levels of Scr,BUN,NGAL,NT-proBNP and CRP in the control group were significantly lower than those at 24 h after PCI,and the levels of eGFR were significantly higher(P<0.05).APACHE Ⅱ score and CIN incidence in the observation group were significantly lower than those in the control group,and the differences were statistically significant(P<0.05).Conclusion CRRT can obviously improve the cardiac and renal functions of patients with acute myocardial infarction complicated with cardiac and renal insufficiency after PCI and reduce the occurrence of CIN,thus being beneficial to the recovery of patients after PCI.
作者 周海涛 毕剑波 陈艳霞 ZHOU Haitao;BI jianbo;CHEN Yanxia(Department of Cardiology,Yangzhong Municipal People's Hospital,Jiangsu Province Yangzhong,Jiangsu 212200)
出处 《中国急救复苏与灾害医学杂志》 2020年第11期1244-1248,共5页 China Journal of Emergency Resuscitation and Disaster Medicine
关键词 持续肾替代治疗 急性心肌梗死 心肾功能不全 经皮冠状动脉介入治疗 对比剂肾病 Continuous renal replacement therapy Acute myocardial infarction Cardiac and renal insufficiency Percutaneous coronary intervention Contrast nephropathy
  • 相关文献

参考文献12

二级参考文献131

  • 1托伐普坦临床研究协作组,张健,朱文玲.常规治疗基础上联用托伐普坦片治疗心原性水肿的有效性和安全性的多中心随机、双盲、安慰剂对照研究[J].中华心力衰竭和心肌病杂志(中英文),2017,1(1):15-21. 被引量:26
  • 2杨新春,张大鹏,王乐丰,徐立,葛永贵,王红石,李惟铭,倪祝华,夏昆,连勇,薛永利,马利祥.冠状动脉内应用国产替罗非班对急性ST段抬高心肌梗死急诊介入治疗后心肌灌注和临床预后的影响[J].中华心血管病杂志,2007,35(6):517-522. 被引量:73
  • 3Klein LW,Sheldon MW,Brinker J,et al.The use of radiographic contrast media during PCI:a focused review:a position statement of the Society of Cardiovascular Angiography and Interventions.Catheter Cardiovasc Interv,2009,74:728-746.
  • 4ESC Guidelines for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes.Chapter Contrast-Induced Nephropathy.Bassand et al.Eur Heart,2007,28:1598-1660.
  • 5中国医师协会心血管内科医师分会,中国医师协会循证医学专业委员会,中国老年学学会心脑血管病专业委员会.心血管疾病防治指南和共识2009.北京:人民卫生出版社,2009.
  • 6Singh J,Daftary A.Iodinated contrast media and their adverse reactions.J Nucl Med Technol,2008,36:69-74.
  • 7Nash K,Hafeez A,Hou S.Hospital-acquired renal insufficiency.Am J Kidney Dis,2002,39:930-936.
  • 8European Society of Urogential Radiology.Guidelines on Contrast Media.Version 6.0,2007.
  • 9McCullough PA,Wolyn R,Rocher LL,et al.Acute renal failure after coronary intervention:incidence,risk factors,and relationship to mortality.Am J Med,1997,103:368-375.
  • 10Mehta RL,Kellum JA,Shah SV,et al.Acute Kidney Injury Network:report of an initiative to improve outcomes in acute kidney injury.Crit Care,2007,11:R31.

共引文献11842

同被引文献58

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部